October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Hagop Kantarjian: Inotuzumab is safe and effective for the eradication of MRD in patients with B-cell ALL, with a MRD negativity rate of 69%
Nov 6, 2023, 03:36

Hagop Kantarjian: Inotuzumab is safe and effective for the eradication of MRD in patients with B-cell ALL, with a MRD negativity rate of 69%

Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared a post on Twitter:

Inotuzumab is safe and effective for the eradication of MRD in patients with B-cell ALL, with a MRD negativity rate of 69%.
Elias Jabbour,
Fadi Haddad, Hagop Kantarjian of MD Anderson Cancer Center.

For the article click here.
Source: Hagop Kantarjian/Twitter